118 related articles for article (PubMed ID: 8383974)
1. Administration of ATG according to the absolute T lymphocyte count during therapy for steroid-resistant rejection.
Clark KR; Forsythe JL; Shenton BK; Lennard TW; Proud G; Taylor RM
Transpl Int; 1993 Jan; 6(1):18-21. PubMed ID: 8383974
[TBL] [Abstract][Full Text] [Related]
2. Effectivity of a T-cell-adapted induction therapy with anti-thymocyte globulin (Sangstat).
Koch A; Daniel V; Dengler TJ; Schnabel PA; Hagl S; Sack FU
J Heart Lung Transplant; 2005 Jun; 24(6):708-13. PubMed ID: 15949731
[TBL] [Abstract][Full Text] [Related]
3. A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients.
Mariat C; Alamartine E; Diab N; de Filippis JP; Laurent B; Berthoux F
Transpl Int; 1998; 11(3):231-6. PubMed ID: 9638854
[TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring.
Abouna GM; al-Abdullah IH; Kelly-Sullivan D; Kumar MS; Loose J; Phillips K; Yost S; Seirka D
Transplantation; 1995 Jun; 59(11):1564-8. PubMed ID: 7778170
[TBL] [Abstract][Full Text] [Related]
5. Improved graft prognosis by treatment of steroid resistant rejections with ATG and plasmapheresis.
Fassbinder W; Scheuermann EH; Stutte HJ; Bechstein PB; Fürsch A; Ernst W; Schoeppe W
Proc Eur Dial Transplant Assoc; 1983; 20():362-7. PubMed ID: 6361750
[TBL] [Abstract][Full Text] [Related]
6. Serial monitoring of T-cell subset ratios with monoclonal antibodies in steroid- and antithymocyte globulin-treated patients with renal allotransplants.
Lewis RE; Kirchner K; Preuss T; Raju S; Krueger R; Cuchens M; Bower JD; Cruse JM
Clin Immunol Immunopathol; 1984 May; 31(2):241-53. PubMed ID: 6232027
[TBL] [Abstract][Full Text] [Related]
7. Antithymocyte globulin for steroid resistant rejection in renal transplant recipients immunosuppressed with triple therapy.
Richardson AJ; Higgins RM; Liddington M; Murie J; Ting A; Morris PJ
Transpl Int; 1989 Apr; 2(1):27-32. PubMed ID: 2669801
[TBL] [Abstract][Full Text] [Related]
8. Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection.
Midtvedt K; Fauchald P; Lien B; Hartmann A; Albrechtsen D; Bjerkely BL; Leivestad T; Brekke IB
Clin Transplant; 2003 Feb; 17(1):69-74. PubMed ID: 12588325
[TBL] [Abstract][Full Text] [Related]
9. [Importance of determining the absolute CD3+ lymphocyte count during induction therapy with antithymocyte globulin in kidney transplantation patients].
Drasković-Pavlović B; Hrvacević R; Ignjatović Lj; Popović P; Colić M
Vojnosanit Pregl; 2000; 57(3):285-90. PubMed ID: 11039308
[TBL] [Abstract][Full Text] [Related]
10. Interruption of anti-thymocyte globuline treatment in solid organ transplantation is effectively monitored through a low total lymphocyte count.
Rasander RO; Sørensen SS; Krohn PS; Bruunsgaard H
Front Immunol; 2024; 15():1419726. PubMed ID: 38933271
[TBL] [Abstract][Full Text] [Related]
11. Low dose antithymocyte globulins in renal transplantation: daily versus intermittent administration based on T-cell monitoring.
Djamali A; Turc-Baron C; Portales P; Leverson G; Chong G; Clot J; Mourad G
Transplantation; 2000 Mar; 69(5):799-805. PubMed ID: 10755529
[TBL] [Abstract][Full Text] [Related]
12. Basiliximab as an alternative to antithymocyte globulin for early immunosuppression in lung transplantation.
Clinckart F; Bulpa P; Jamart J; Eucher P; Delaunois L; Evrard P
Transplant Proc; 2009 Mar; 41(2):607-9. PubMed ID: 19328937
[TBL] [Abstract][Full Text] [Related]
13. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation.
Colak T; Sevmiş S; Karakayali H; Moray G; Haberal M
Transplant Proc; 2008; 40(1):123-5. PubMed ID: 18261564
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of OKT3 monoclonal antibody and anti-thymocyte globulin in the treatment of steroid-resistant acute allograft rejection in pediatric renal transplants.
Mochon M; Kaiser B; Palmer JA; Polinsky M; Flynn JT; Caputo GC; Baluarte HJ
Pediatr Nephrol; 1993 Jun; 7(3):259-62. PubMed ID: 8518094
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of CD3(+) T-cell count in patients receiving antithymocyte globulin induction after cadaveric renal transplantation.
Ata P; Kara M; Özdemir E; Canbakan M; Gökçe AM; Bayraktar FA; Şahin G; Özel L; Titiz MI
Transplant Proc; 2013 Apr; 45(3):929-31. PubMed ID: 23622590
[TBL] [Abstract][Full Text] [Related]
16. CD2+, CD3+, and CD19+ depletion after a course of antithymocyte globulin for a steroid-resistant rejection.
Grandtnerovà B; Mocikovà H; Kohutovà M
Transplant Proc; 1997 Nov; 29(7):2958-9. PubMed ID: 9365628
[No Abstract] [Full Text] [Related]
17. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft.
Grinyó JM; Gil-Vernet S; Seron D; Hueso M; Fulladosa X; Cruzado JM; Moreso F; Fernandez A; Torras J; Riera L; Castelao AM; Alsina J
Nephrol Dial Transplant; 1998 Oct; 13(10):2601-4. PubMed ID: 9794567
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
[TBL] [Abstract][Full Text] [Related]
19. T-cell count and antilymphocyte globulin therapy.
Ippoliti G; Martinelli L; Negri M; Abelli P; Viganò M
Transpl Int; 1994; 7(2):146. PubMed ID: 8179805
[No Abstract] [Full Text] [Related]
20. Muromonab-CD3 and antithymocyte globulin in renal transplantation.
Burk ML; Matuszewski KA
Ann Pharmacother; 1997 Nov; 31(11):1370-7. PubMed ID: 9391693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
